Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 623

Results For "IT"

10429 News Found

PM Modi launches and inaugurates Rs. 12,850 crore health projects at AIIA, New Delhi
News | October 30, 2024

PM Modi launches and inaugurates Rs. 12,850 crore health projects at AIIA, New Delhi

These initiatives signify a substantial boost to healthcare infrastructure across India, aligned with the Prime Minister’s mission of ensuring quality healthcare services nationwide


MRP of anti-cancer drugs to come down due to custom duty exemption and GST rate reduction
Policy | October 30, 2024

MRP of anti-cancer drugs to come down due to custom duty exemption and GST rate reduction

This is in pursuance to the announcement made in the Union Budget for the year 2024-25 exempting these three anti-cancer medicines from customs duty


AIIMS Delhi hosts workshop on ‘Emerging Technologies for Healthcare’
News | October 28, 2024

AIIMS Delhi hosts workshop on ‘Emerging Technologies for Healthcare’

The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power


Strides Pharma Science reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr
News | October 28, 2024

Strides Pharma Science reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr

Strides Pharma Science has reported total income of Rs. 1,229.52 crores during the period ended September 30, 2024


Indoco Remedies posts Q2 FY25 consolidated loss at Rs. 9.57 Cr
News | October 28, 2024

Indoco Remedies posts Q2 FY25 consolidated loss at Rs. 9.57 Cr

Indoco Remedies has reported total income of Rs. 434.22 crores during the period ended September 30, 2024


Laurus Labs posts Q2 FY25 consolidated PAT at Rs. 19.84 Cr
News | October 28, 2024

Laurus Labs posts Q2 FY25 consolidated PAT at Rs. 19.84 Cr

Laurus Labs has reported total income of Rs. 1,228.30 crores during the period ended September 30, 2024


Piramal Pharma reports Q2 FY25 consolidated PAT at Rs. 22.59 Cr
News | October 25, 2024

Piramal Pharma reports Q2 FY25 consolidated PAT at Rs. 22.59 Cr

Piramal Pharma has reported total income of Rs. 2,302.86 crores during the period ended September 30, 2024


Aptar bags contract to advance novel sterilization technology for medical devices
Medical Device | October 23, 2024

Aptar bags contract to advance novel sterilization technology for medical devices

ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure


Jubilant Ingrevia appoints Vijay Srivastava as Chief of Operations
People | October 23, 2024

Jubilant Ingrevia appoints Vijay Srivastava as Chief of Operations

He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates